Scott Garland

2018 - Portola Pharmaceuticals

In 2018, Scott Garland earned a total compensation of $5.8M as President and Chief Executive Officer at Portola Pharmaceuticals.

Compensation breakdown

Bonus$200,000
Non-Equity Incentive Plan$70,400
Option Awards$2,889,625
Salary$144,631
Stock Awards$2,461,250
Other$3,125
Total$5,769,031

Garland received $2.9M in option awards, accounting for 50% of the total pay in 2018.

Garland also received $200K in bonus, $70.4K in non-equity incentive plan, $144.6K in salary, $2.5M in stock awards and $3.1K in other compensation.

Rankings

In 2018, Scott Garland's compensation ranked 1,655th out of 14,244 executives tracked by ExecPay. In other words, Garland earned more than 88.4% of executives.

ClassificationRankingPercentile
All
1,655
out of 14,244
88th
Division
Manufacturing
590
out of 5,765
90th
Major group
Chemicals And Allied Products
187
out of 2,128
91st
Industry group
Drugs
148
out of 1,817
92nd
Industry
Pharmaceutical Preparations
109
out of 1,391
92nd
Source: SEC filing on April 19, 2019.

Garland's colleagues

We found six more compensation records of executives who worked with Scott Garland at Portola Pharmaceuticals in 2018.

2018

William Lis

Portola Pharmaceuticals

Chief Executive Officer

2018

John Moriarty

Portola Pharmaceuticals

General Counsel

2018

Glenn Brame

Portola Pharmaceuticals

Executive Vice President, Chief Technical Operations Officer

2018

Ernie Meyer

Portola Pharmaceuticals

Chief Human Resources Officer

2018

Mardi Dier

Portola Pharmaceuticals

Executive Vice President, Chief Financial and Business Officer

2018

John Curnutte

Portola Pharmaceuticals

Executive Vice President, Research and Development

News

In-depth

You may also like